Treace Medical Concepts, Inc.
TMCINasdaqCIK 1630627HealthcareFiscal year ends Dec 31
Reports and events: 77 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0707:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001630627-26-000018 |
| 2026-08-0707:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001630627-26-000017 |
| 2026-05-2017:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001630627-26-000014 |
| 2026-05-0807:10 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-213322 |
| 2026-05-0807:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213267 |
| 2026-04-0907:00 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001630627-26-000010 |
| 2026-04-0608:48 ET | DEF 14A | Proxy statementPeriod 2026-04-03 | 0001630627-26-000005 |
| 2026-02-2707:14 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-079167 |
| 2026-02-2707:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-079163 |
| 2026-01-1308:54 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-011177 |
| 2025-12-1808:44 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-323802 |
| 2025-11-0616:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269556 |
| 2025-11-0616:07 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-269481 |
| 2025-08-0716:17 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105059 |
| 2025-08-0716:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105039 |
| 2025-05-2116:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-075805 |
| 2025-05-0816:10 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066953 |
| 2025-05-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066915 |
| 2025-04-0708:10 ET | DEF 14A | Proxy statementPeriod 2025-04-07 | 0000950170-25-051369 |
| 2025-04-0708:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-051362 |
| 2025-02-2716:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029029 |
| 2025-02-2716:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-029009 |
| 2025-01-1308:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004578 |
| 2024-11-0516:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-121460 |
| 2024-11-0516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121456 |
| 2024-10-1516:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-114699 |
| 2024-08-0616:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-091787 |
| 2024-08-0616:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091777 |
| 2024-05-2217:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-063565 |
| 2024-05-0716:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-054480 |
| 2024-05-0716:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-054475 |
| 2024-04-0216:30 ET | DEF 14A | Proxy statementPeriod 2024-04-02 | 0000950170-24-040228 |
| 2024-02-2716:29 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-021228 |
| 2024-02-2716:13 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-021152 |
| 2024-01-1018:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-003448 |
| 2024-01-0808:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-002719 |
| 2023-11-0916:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062068 |
| 2023-11-0916:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062026 |
| 2023-08-0908:09 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040159 |
| 2023-08-0816:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039795 |
| 2023-06-1317:09 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0000950170-23-027758 |
| 2023-06-0116:18 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-025707 |
| 2023-05-2617:19 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-024559 |
| 2023-05-0908:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-019154 |
| 2023-05-0816:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-018823 |
| 2023-04-0407:20 ET | DEF 14A | Proxy statementPeriod 2023-05-23 | 0000950170-23-011691 |
| 2023-03-1016:13 ET | 8-K | 8.01 Other events | 0000950170-23-007283 |
| 2023-03-0809:09 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-006603 |
| 2023-03-0716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-006457 |
| 2023-02-2316:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-004148 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:31 ET. Listed shows no prices and gives no investment advice.